Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease
about
Kainate receptor activation induces mixed lineage kinase-mediated cellular signaling cascades via post-synaptic density protein 95Cellular localization and development of neuronal intranuclear inclusions in striatal and cortical neurons in R6/2 transgenic miceA series of N-terminal epitope tagged Hdh knock-in alleles expressing normal and mutant huntingtin: their application to understanding the effect of increasing the length of normal Huntingtin's polyglutamine stretch on CAG140 mouse model pathogenesiTranscriptional dysregulation in striatal projection- and interneurons in a mouse model of Huntington's disease: neuronal selectivity and potential neuroprotective role of HAP1.Wheel running from a juvenile age delays onset of specific motor deficits but does not alter protein aggregate density in a mouse model of Huntington's disease.Seeking brain biomarkers for preventive therapy in Huntington disease.Striatal Vulnerability in Huntington's Disease: Neuroprotection Versus Neurotoxicity.A selective inhibitor of histone deacetylase 3 prevents cognitive deficits and suppresses striatal CAG repeat expansions in Huntington's disease miceExpanded polyglutamines in Caenorhabditis elegans cause axonal abnormalities and severe dysfunction of PLM mechanosensory neurons without cell deathOf mice and men: solving the molecular mysteries of Huntington's disease.Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease.Effect of enhanced voluntary physical exercise on brain levels of monoamines in Huntington disease miceInhibition of tryptophan hydroxylase activity and decreased 5-HT1A receptor binding in a mouse model of Huntington's disease.Pathology of CAG repeat diseases.The selective vulnerability of nerve cells in Huntington's disease.Loss of SNAP-25 and rabphilin 3a in sensory-motor cortex in Huntington's disease.Thalamic metabolism and symptom onset in preclinical Huntington's disease.Striatal infusion of glial conditioned medium diminishes huntingtin pathology in r6/1 mice.Changes in striatal procedural memory coding correlate with learning deficits in a mouse model of Huntington diseaseGenotype-phenotype correlation in CAG-repeat diseases.In vivo Dopamine Efflux is Decreased in Striatum of both Fragment (R6/2) and Full-Length (YAC128) Transgenic Mouse Models of Huntington's Disease.Huntington's Disease and Striatal Signaling.Functional changes in postsynaptic adenosine A(2A) receptors during early stages of a rat model of Huntington diseaseSleep Physiology Alterations Precede Plethoric Phenotypic Changes in R6/1 Huntington's Disease MiceDysregulation of dopamine receptor D2 as a sensitive measure for Huntington disease pathology in model miceGlutamate receptor abnormalities in the YAC128 transgenic mouse model of Huntington's disease.The paradigm of Huntington's disease: therapeutic opportunities in neurodegeneration.The protective effect of adenosine A2A receptor antagonism in cerebral ischemia.Inhibition of Excessive Monoamine Oxidase A/B Activity Protects Against Stress-induced Neuronal Death in Huntington Disease.Novel therapeutic targets for Huntington's disease.Therapeutics development for triplet repeat expansion diseases.The use of the R6 transgenic mouse models of Huntington's disease in attempts to develop novel therapeutic strategies.Monitoring Huntington's disease progression through preclinical and early stagesPolyglutamine disease: recent advances in the neuropathology of dentatorubral-pallidoluysian atrophy.Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington's disease phenotypes in miceAllelic series of Huntington's disease knock-in mice reveals expression discorrelates.Transcriptional signatures in Huntington's disease.Drug targeting of dysregulated transcription in Huntington's diseaseRegulators of adult neurogenesis in the healthy and diseased brain.Huntington's disease: progress and potential in the field.
P2860
Q28142396-8F556251-59BD-43DD-8AF6-420DA31F0C65Q28510296-47A0AAD9-5ADE-4ADD-815A-89D786FEBCC9Q30423904-88E27FD5-7B26-4828-AB58-D589984E4517Q31129663-52E9B524-6956-4EF7-9616-E89871C2D4BFQ33326475-1E16C112-DFDB-405E-8643-68637CC77C55Q33606063-8A4DA273-4663-404F-B707-BC2517EA3DF1Q33831774-B03037D9-DA9C-4290-A3CF-671006DDA772Q33920945-5633D3A6-9A42-4D80-AD80-A4BCC198C5A7Q33949349-161A9E87-88BD-419F-A6A4-8A9209AED3EBQ33989379-E27EED99-642F-4B72-96EB-2DABDECCB985Q34075502-88E8F9B7-C48F-48BF-AD48-F0A8C6A1885EQ34135360-89C77B9C-E59B-41D8-8ACB-9DBE49192DF8Q34152284-7107CD69-7A0B-4935-8F92-5E3C644D4244Q34158005-C67B2936-2D63-45D0-BEC8-11D27F5EBAD7Q34216757-4C5F6A77-97BB-4AEF-A8A8-5F053F099A7DQ34689527-389ECA8E-8636-4F63-B895-7BB33F336845Q34692568-8F14EA70-9D61-4A70-B709-3982E3AA7826Q34998578-20CE1395-7A84-4A46-9C43-448F7F8D46F1Q35022005-3919D80E-A2E6-4055-963B-EDBB167364ECQ35058863-66BA5321-B6DC-482D-A4DF-8D4786451F5AQ35116551-3E86A2D6-1F9B-4635-87EB-0B2F67314F54Q35286098-924CCFED-4129-42B0-8F4F-E2F5482399D2Q35300868-EC63535C-7DC4-47EE-B9B7-A6A12577851DQ35597460-69822BDE-3C4B-4155-B0F1-229C8905978EQ35982759-63337817-BCC2-4EF3-9262-13982C462B7CQ36016647-864B2140-B359-4DB2-872C-6F87D96DF109Q36045254-11DD978A-43F6-4892-9608-92B65B0E82BBQ36097335-D33AB943-4C45-4BAE-AD4E-52D46AECCBEDQ36100251-25D5F1D4-691A-4561-83B9-9589DE173DF0Q36219680-3075610D-18E0-4EC2-86B9-BF5747753D9AQ36277195-5196087D-4D09-4E5B-871C-CC859E3C1E97Q36358871-BAAACBE0-7EF6-426A-BA8F-8D7EA4B10C14Q36459201-DEF6E453-D137-4C3A-991A-F58AFD900651Q36589169-6B85508D-FD2E-4342-AA00-7067CEDDF5D0Q36648659-27008A59-66B8-49B0-9388-FD9B8AE62F74Q36722685-D3579874-0188-4DD6-B994-A645C07CB849Q36752799-E03EB5D8-542D-490C-ABF2-1CAE42606FBCQ36767264-ED283A67-4D64-4142-8E37-F1BAB632A6E7Q36793913-8323350E-82D5-439B-A309-675C64B5EF31Q37016096-676F1703-248B-4C2F-8A18-686AC1E3C5FF
P2860
Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Altered neurotransmitter recep ...... models of Huntington's disease
@ast
Altered neurotransmitter recep ...... models of Huntington's disease
@en
type
label
Altered neurotransmitter recep ...... models of Huntington's disease
@ast
Altered neurotransmitter recep ...... models of Huntington's disease
@en
prefLabel
Altered neurotransmitter recep ...... models of Huntington's disease
@ast
Altered neurotransmitter recep ...... models of Huntington's disease
@en
P2093
P2860
P356
P1476
Altered neurotransmitter recep ...... models of Huntington's disease
@en
P2093
C M Kosinski
J A Kerner
J B Penney
L Mangiarini
S A Alsdorf
S W Davies
P2860
P304
P356
10.1098/RSTB.1999.0449
P407
P577
1999-06-01T00:00:00Z